We provide two services: OncoAct and Hartwig Sequencing Services.
Cancer is caused by DNA mutations. To find these mutations, we developed OncoAct. OncoAct is a complete DNA test that can provide physicians with additional information about clinically relevant characteristics of a tumor (biomarkers) that may also be predictive of the response to treatment.
Changes in the genetic profile (mutations) sometimes provide clues to a potential treatment that can directly target these mutations. This is known as targeted therapy.
In addition, the OncoAct report contains possible leads for trials or experimental drugs.
We sequence and analyze DNA for research purposes.
We are proud that we succeeded in implementing the complete DNA test in standard of care diagnostics, together with Hartwig Medical Foundation. Moreover, the test produces vital information for a learning healthcare system in oncology. We will be able to treat future patients even more effectively.